PCSA | Processa Pharmaceuticals Announces the Appointment of Dr. Khalid Islam to Its Board of Directors

HANOVER, MD, Nov.05, 2020 (GLOBE NEWSWIRE) — Processa Pharmaceuticals, Inc.(NASDAQ: PCSA), (“Processa” or the “Company”), a clinical-stage biopharmaceutical company developing products to improve the survival and/or quality of life for patients who have a high unmet medical need, is pleased to announce the appointment of Dr.Khalid Islam to its board of directors.GlobeNewswire